Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Per Fauchald"'
Autor:
Hallvard Holdaas, Geir Mjøen, Henrik Andreas Bergrem, Karsten Midtvedt, Ingar Holme, Ole Øyen, Per Fauchald
Publikováno v:
Transplant International. 24:73-77
Summary It is considered safe to donate a kidney if internationally accepted medical criteria are fulfilled. However, some donors have encountered hypertension, proteinuria and impaired renal function after donation. The study was based on retrospect
Autor:
Anders Åsberg, Janicke Narverud, Anna Varberg Reisæter, Karsten Midtvedt, Hallvard Holdaas, Pål D. Line, Trond Jenssen, Per Fauchald, Linda Flaa Johnsen, Anders Hartmann
Publikováno v:
Transplantation. 82:62-68
Background. Calcineurin inhibitor (CNI)-free regimens posttransplantation have been claimed to conserve graft function in addition to reduce the risk factors for cardiovascular and malignant disease in renal transplant recipients. Methods. The primar
Autor:
Terje R. Pedersen, Patrice M. Ambühl, Bengt Fellström, Hans-Hellmut Neumayer, Per Fauchald, Gudrun Nyberg, Anders Hartmann, Bart Maes, Anders G. Olsson, Hallvard Holdaas, Ingar Holme, Søren Madsen, Carola Grönhagen-Riska, John Logan, Edward S. Cole, Alan G. Jardine
Publikováno v:
Kidney International. 66:1549-1555
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.BackgroundHyperlipidemia is a risk factor for long-term renal transplant dysfunction, but no prospective clinical trials have investigated the eff
Autor:
Klemens Budde, Lutz Fritsche, J. Dantal, Ingeborg A. Hauser, Jean-Paul Soulillou, Gustav Lehne, Hans-Hellmut Neumayer, Michael Winkler, Arno Lison, Per Fauchald
Publikováno v:
Nephrology Dialysis Transplantation. 19:2606-2614
Background. Current immunosuppressant regimens need to be improved to prevent acute and chronic graft rejection. The novel macrocyclic immunosuppressant everolimus (Certican TM , RAD) is currently in clinical development to address this issue. Method
Autor:
Aksel Foss, Kjell Rootwelt, Knut P. Nordal, Hallvard Holdaas, Karsten Midtvedt, Per Fauchald, Anders Hartmann
Publikováno v:
Transplantation. 72:1787-1792
BACKGROUND Treatment of posttransplant hypertension is still a matter of debate. Calcium antagonists may ameliorate renal side effects of cyclosporin. Angiotensin converting enzyme- (ACE) inhibitors may be more effective in sustaining renal function
Autor:
James G. Heaf, Henryk E. Wilczek, John M. Kovarik, Hans Løkkegaard, E A Mueller, Knut P. Nordal, Per Fauchald, Jan Wahlberg, Klaus Olgaard, Jesper Melchior Hansen
Publikováno v:
Europe PubMed Central
To evaluate the pharmacokinetic properties of the new microemulsion formulation of cyclosporine (Sandimmun Neoral), a double-blind, prospective study in stable renal transplant recipients was performed. The patients were randomized on a 4:1 basis eit
Autor:
Johan Kofstad, Solbjørg Sagedal, Frank Brosstad, Kåre Osnes, Josephine Torremocha, Per Fauchald, Stine Bjørnsen, Anders Hartmann
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 21(2)
Background. Heparin-free haemodialysis (HD) with intermittent saline flushes (ISF) in patients with bleeding risk is widely used. The aim of this study was to investigate if ISF reduce coagulation and clotting in stable patients receiving reduced dos
Autor:
Michael Winkler, Lutz Fritsche, J. Dantal, Lutz Renders, Arno Lison, Jean-Paul Soulillou, Klemens Budde, Hans H. Neumayer, Per Fauchald, Gustav Lehne
Publikováno v:
Journal of clinical pharmacology. 45(7)
To investigate possible interactions of the novel immunosuppressant everolimus with cyclosporine, a multicenter, randomized, double-blind, placebo-controlled, dose-escalating phase I study was performed. Everolimus regimens (0.75-10 mg/d) were admini
Autor:
Audun Flatmark, Torbjørn Leivestad, Anders Hartmann, Dagfinn Albrechtsen, Per Fauchald, Hallvard Holdaas, Gunnar Sødal, Anna Varberg Reisæter
Publikováno v:
Transplantation. 60(3)
Patients with preformed antibodies against HLA molecules accumulate on renal transplant waiting lists and have inferior graft survival compared with nonsensitized patients. One hundred patients were included in a program of pretransplant removal of a
Publikováno v:
American heart journal. 121(1 Pt 2)
The study was designed to investigate the safety and efficacy of doxazosin in the control of blood pressure in general medical practice; the results presented concern the first 748 patients evaluated over a 12-week period. Blood pressure was signific